Literature DB >> 24042987

Dissociations in the meaning of risk between health-care professionals and individuals with spinal cord injury.

M Eijkholt1, B K Kwon, J Illes.   

Abstract

OBJECTIVE: Risks have been a central concern in stem cell research overall, and in clinical trials of individuals with spinal cord injury (ISCIs) in particular. We sought to elucidate how two important stakeholder groups-health-care professionals (HCPs) and ISCIs-view and value both the physical and non-physical risks of stem cell interventions.
SETTING: The study was conducted in Canada, and included participants from both Canada and the United States America. STUDY
DESIGN: We used semi-structured interviews to gain perspectives on risk from HCPs and ISCIs.
METHODS: We applied a constant comparative analytic strategy to derive themes from the discourse collected through the interviews.
RESULTS: We identified three major themes about risk from 12 HCP and 24 ISCI participants: focus, rationale and approach. The salient components of the themes differed: HCPs focus on the physical causes of risks, and the ISCIs on their downstream consequences as well as on non-physical risks; HCPs are concerned about evidence, and ISCIs about experience; and HCPs approach risk narrowly, whereas the approach of ISCIs is more broad and contextualized.
CONCLUSION: Although major themes were common to the two stakeholder groups, the components of the themes were dissociable and illustrate differences in what HCPs and ISCIs worry about, why they worry and how they approach their worries. We draw upon these findings to make recommendations for improving risk communication and informed consent for stem cell research for spinal cord injury.

Entities:  

Mesh:

Year:  2013        PMID: 24042987     DOI: 10.1038/sc.2013.103

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  3 in total

Review 1.  The challenge of recruitment for neurotherapeutic clinical trials in spinal cord injury.

Authors:  Andrew R Blight; Jane Hsieh; Armin Curt; James W Fawcett; James D Guest; Naomi Kleitman; Shekar N Kurpad; Brian K Kwon; Daniel P Lammertse; Norbert Weidner; John D Steeves
Journal:  Spinal Cord       Date:  2019-04-08       Impact factor: 2.772

2.  Perspectives on strategies and challenges in the conversation about stem cells for spinal cord injury.

Authors:  K J Jacob; B K Kwon; C Lo; J Snyder; J Illes
Journal:  Spinal Cord       Date:  2015-06-02       Impact factor: 2.772

3.  Novel Neurotechnological Interventions for Pediatric Drug-Resistant Epilepsy: Physician Perspectives.

Authors:  Patrick J McDonald; Viorica Hrincu; Mary B Connolly; Mark J Harrison; George M Ibrahim; Robert P Naftel; Winston Chiong; Farhad Udwadia; Judy Illes
Journal:  J Child Neurol       Date:  2020-10-28       Impact factor: 1.987

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.